14
Jul
2026
A Schizophrenia Drug Patients Can Stick With: Heather Turner on The Long Run
Heather Turner is today’s guest on The Long Run. Heather is the CEO of New York-based LB Pharmaceuticals. It’s developing treatments for serious mental health disorders such as schizophrenia, depression, and bipolar disorder. The company is running late-stage clinical trials for its lead drug candidate, LB102. It’s a methylated derivative of amisulpride, a benzamide antipsychotic. It’s approved in more than... Read More